These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia. Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987 [TBL] [Abstract][Full Text] [Related]
6. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia. Minami K; Haji T Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464 [TBL] [Abstract][Full Text] [Related]
7. Intranasal bevacizumab injections improve quality of life in HHT patients. Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573 [TBL] [Abstract][Full Text] [Related]
8. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial. Yaniv E; Preis M; Shevro J; Nageris B; Hadar T Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879 [TBL] [Abstract][Full Text] [Related]
9. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life. Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465 [TBL] [Abstract][Full Text] [Related]
10. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis. Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172 [TBL] [Abstract][Full Text] [Related]
11. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis. Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816 [TBL] [Abstract][Full Text] [Related]
12. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451 [TBL] [Abstract][Full Text] [Related]
13. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Yaniv E; Preis M; Hadar T; Shvero J; Haddad M Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429 [TBL] [Abstract][Full Text] [Related]
14. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial. Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649 [TBL] [Abstract][Full Text] [Related]